TEST DELETE ME - Revision history

NeilArmstrong: Added a glossary link to Action~

2012-07-29T18:17:40Z

Added a glossary link to Action~

← Older revision		Revision as of 18:17, 29 July 2012
Line 62:		Line 62:
	(Add details here)		(Add details here)

	'''ACTION ITEMS / NEXT STEPS'''		'''[[ACTION~\|Action]] ITEMS / NEXT STEPS'''
	(Add details here)		(Add details here)

	'''OPEN ISSUES / QUESTIONS'''		'''OPEN ISSUES / QUESTIONS'''
	(Add details here)		(Add details here)

NeilArmstrong: Added a glossary link to record~

2012-04-01T14:07:54Z

Added a glossary link to record~

← Older revision		Revision as of 14:07, 1 April 2012
Line 10:		Line 10:
	'''CERTIFICATION CRITERION'''		'''CERTIFICATION CRITERION'''
	Final Rule Text: §170.304(i)		Final Rule Text: §170.304(i)
	(1) Electronically receive and display. Electronically receive and display a patient’s summary record, from other providers and organizations including, at a minimum, diagnostic tests results, problem list, medication list, and medication [[allergy~\|Allergy]] list in accordance with the standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2).		(1) Electronically receive and display. Electronically receive and display a patient’s summary [[record~\|Record]], from other providers and organizations including, at a minimum, diagnostic tests results, problem list, medication list, and medication [[allergy~\|Allergy]] list in accordance with the standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2).
	Upon receipt of a patient summary record formatted according to the alternative standard, display it in human readable format.		Upon receipt of a patient summary [[record~\|Record]] formatted according to the alternative standard, display it in human readable format.
	(2) Electronically transmit. Enable a user to electronically transmit a patient summary record to other providers and organizations including, at a minimum, diagnostic test results, problem list, medication list, and medication [[allergy~\|Allergy]] list in accordance with:		(2) Electronically transmit. Enable a user to electronically transmit a patient summary [[record~\|Record]] to other providers and organizations including, at a minimum, diagnostic test results, problem list, medication list, and medication [[allergy~\|Allergy]] list in accordance with:
	(i) The standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2); and		(i) The standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2); and
	(ii) For the following data elements the applicable standard must be used:		(ii) For the following data elements the applicable standard must be used:

NeilArmstrong: Added glossary link to Allergy~

2012-02-22T07:41:05Z

Added glossary link to Allergy~

← Older revision		Revision as of 07:41, 22 February 2012
Line 10:		Line 10:
	'''CERTIFICATION CRITERION'''		'''CERTIFICATION CRITERION'''
	Final Rule Text: §170.304(i)		Final Rule Text: §170.304(i)
	(1) Electronically receive and display. Electronically receive and display a patient’s summary record, from other providers and organizations including, at a minimum, diagnostic tests results, problem list, medication list, and medication allergy list in accordance with the standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2).		(1) Electronically receive and display. Electronically receive and display a patient’s summary record, from other providers and organizations including, at a minimum, diagnostic tests results, problem list, medication list, and medication [[allergy~\|Allergy]] list in accordance with the standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2).
	Upon receipt of a patient summary record formatted according to the alternative standard, display it in human readable format.		Upon receipt of a patient summary record formatted according to the alternative standard, display it in human readable format.
	(2) Electronically transmit. Enable a user to electronically transmit a patient summary record to other providers and organizations including, at a minimum, diagnostic test results, problem list, medication list, and medication allergy list in accordance with:		(2) Electronically transmit. Enable a user to electronically transmit a patient summary record to other providers and organizations including, at a minimum, diagnostic test results, problem list, medication list, and medication [[allergy~\|Allergy]] list in accordance with:
	(i) The standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2); and		(i) The standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2); and
	(ii) For the following data elements the applicable standard must be used:		(ii) For the following data elements the applicable standard must be used:

Peterbodtke at 03:17, 18 August 2010

2010-08-18T03:17:12Z

← Older revision		Revision as of 03:17, 18 August 2010
Line 1:		Line 1:
	'''SECTION # ''': Section 170.304(i)—Exchange Clinical Information ~~and Patient Summary Record~~		'''SECTION # '''
			Section 170.304(i)—Exchange Clinical Information

	'''MU OBJECTIVE'''		'''MU OBJECTIVE'''
	Capability to exchange key clinical information (for example~~, discharge summary, procedures~~, problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically.		Capability to exchange key clinical information (for example, problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically.

	The EP, eligible hospital or CAH who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary of care record for each transition of care or referral.

	'''MU STAGE 1 MEASURE'''		'''MU STAGE 1 MEASURE'''
	Performed at least one test of certified EHR technology's capacity to electronically exchange key clinical information.		Performed at least one test of certified EHR technology's capacity to electronically exchange key clinical information.
	The EP, eligible hospital or CAH who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals.

	'''CERTIFICATION CRITERION'''		'''CERTIFICATION CRITERION'''
	Final Rule Text: §170.304(i)		Final Rule Text: §170.304(i)
	(1) Electronically receive and display. Electronically receive and display a patient’s summary record, from other providers and organizations including, at a minimum, diagnostic tests results, problem list, medication list, and medication allergy list in accordance with the standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2).		(1) Electronically receive and display. Electronically receive and display a patient’s summary record, from other providers and organizations including, at a minimum, diagnostic tests results, problem list, medication list, and medication allergy list in accordance with the standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2).
	Upon receipt of a patient summary record formatted according to the alternative standard, display it in human readable format.		Upon receipt of a patient summary record formatted according to the alternative standard, display it in human readable format.

	(2) Electronically transmit. Enable a user to electronically transmit a patient summary record to other providers and organizations including, at a minimum, diagnostic test results, problem list, medication list, and medication allergy list in accordance with:		(2) Electronically transmit. Enable a user to electronically transmit a patient summary record to other providers and organizations including, at a minimum, diagnostic test results, problem list, medication list, and medication allergy list in accordance with:
	(i) The standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2); and		(i) The standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2); and
Line 41:		Line 38:
	\|-		\|-
	\| All		\| All
	\| ~~MENU~~		\| CORE
	\| WorldVistA, et al		\| WorldVistA, et al
	\| TBD		\| TBD
Line 47:		Line 44:
	----		----
	'''SOLUTION DESIGN / TECHNOLOGY'''		'''SOLUTION DESIGN / TECHNOLOGY'''

	(Add details here)		(Add details here)

	'''DELIVERABLE'''		'''DELIVERABLE'''

	(Add details here - Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)		(Add details here - Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)

Line 58:		Line 53:

	'''COMMENTS / NOTES'''		'''COMMENTS / NOTES'''

	(Add details here)		(Add details here)

	'''PREVIOUS NOTES'''		'''PREVIOUS NOTES'''
	(1) This capability will be provided by the code coming from the CCR-CCD project. The latest project code can be found on http://trac.opensourcevista.net and there are calls almost every Tuesday night at 9 PM Eastern to work on the project. You can sign up to receive notices of the meetings at http://groups.google.com/group/ccd-ccr-project?hl=en . Both a CCR and CCD level 2 are being produced at this time and we are hoping that there will be the capability of transmitting a CCD level 3 in the future as that work is underway. WorldVistA will be submitting a recommendation to the ONCHIT to use both the CCR and CCD as standards for transmission of these health summaries. The production of an XSLT transform to create a CCD level 3 from a CCR, which is the current goal of some work being done by Ken Miller of Solventus as an open source project funded by Oroville Hopital in California, should make this easily possible for healthcare providers.		(1) This capability will be provided by the code coming from the CCR-CCD project. The latest project code can be found on http://trac.opensourcevista.net and there are calls almost every Tuesday night at 9 PM Eastern to work on the project. You can sign up to receive notices of the meetings at http://groups.google.com/group/ccd-ccr-project?hl=en . Both a CCR and CCD level 2 are being produced at this time and we are hoping that there will be the capability of transmitting a CCD level 3 in the future as that work is underway. WorldVistA will be submitting a recommendation to the ONCHIT to use both the CCR and CCD as standards for transmission of these health summaries. The production of an XSLT transform to create a CCD level 3 from a CCR, which is the current goal of some work being done by Ken Miller of Solventus as an open source project funded by Oroville Hopital in California, should make this easily possible for healthcare providers.

	(2)This will also be covered by the CCR-CCD project. Either a CCR or CCD level 2 is something that can be extracted at this time. (see above) This particular standard does not specify how the transmission must be done. It is clear that it must be encrypted but it is not clear how it may be transmitted. Then NHIN is mentioned but there it is not clear that other methods of transport are not allowed such as email with an encrypted attachment. (There is mention that if it is physically transported outside of a healthcare facility, it should be encrypted.)		(2)This will also be covered by the CCR-CCD project. Either a CCR or CCD level 2 is something that can be extracted at this time. (see above) This particular standard does not specify how the transmission must be done. It is clear that it must be encrypted but it is not clear how it may be transmitted. Then NHIN is mentioned but there it is not clear that other methods of transport are not allowed such as email with an encrypted attachment. (There is mention that if it is physically transported outside of a healthcare facility, it should be encrypted.)

	'''DEVELOPMENT STATUS'''		'''DEVELOPMENT STATUS'''

	(Add details here)		(Add details here)

	'''ACTION ITEMS / NEXT STEPS'''		'''ACTION ITEMS / NEXT STEPS'''

	(Add details here)		(Add details here)

	'''OPEN ISSUES / QUESTIONS'''		'''OPEN ISSUES / QUESTIONS'''

	(Add details here)		(Add details here)

Peterbodtke at 23:35, 17 August 2010

2010-08-17T23:35:12Z

← Older revision		Revision as of 23:35, 17 August 2010
Line 1:		Line 1:
	'''SECTION # ''': Section 170.304(i)—Exchange Clinical Information and Patient Summary Record		'''SECTION # ''': Section 170.304(i)—Exchange Clinical Information and Patient Summary Record

	'''MU OBJECTIVE''':		'''MU OBJECTIVE'''
	Capability to exchange key clinical information (for example, discharge summary, procedures, problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically.		Capability to exchange key clinical information (for example, discharge summary, procedures, problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically.
	~~The EP, el~~

	'''MU STAGE 1 MEASURE''': Performed at least one test of certified EHR technology's capacity to electronically exchange key clinical information.		The EP, eligible hospital or CAH who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary of care record for each transition of care or referral.

			'''MU STAGE 1 MEASURE'''
			Performed at least one test of certified EHR technology's capacity to electronically exchange key clinical information.
	The EP, eligible hospital or CAH who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals.		The EP, eligible hospital or CAH who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals.

Line 19:		Line 21:
	(B) Laboratory test results. At a minimum, the version of the standard specified in §170.207(c); and		(B) Laboratory test results. At a minimum, the version of the standard specified in §170.207(c); and
	(C) Medications. The standard specified in §170.207(d).		(C) Medications. The standard specified in §170.207(d).

	~~'''TEST CRITERIA #'''~~
	~~§170.304(i)~~
	~~http://healthcare.nist.gov/docs/170.304.i_ExchangeClinicalinforPatientSummaryRecordAmb_v1.0.pdf~~

	'''STANDARDS'''		'''STANDARDS'''
Line 32:		Line 30:
	§170.207(c)		§170.207(c)
	§170.207(d)		§170.207(d)

			'''TEST CRITERIA #'''
			§170.304(i)
			http://healthcare.nist.gov/docs/170.304.i_ExchangeClinicalinforPatientSummaryRecordAmb_v1.0.pdf
	{\| class="grey" border="1" cellpadding="2"		{\| class="grey" border="1" cellpadding="2"
	! USERS		! USERS
	! CORE / MENU		! CORE / MENU
	! ~~DEVELOPMENT OWNER~~		! SOLUTION DEVELOPERS
	! STATUS		! STATUS
	\|-		\|-
Line 43:		Line 45:
	\| TBD		\| TBD
	\|}		\|}
			----
	'''SOLUTION DESIGN / TECHNOLOGY'''		'''SOLUTION DESIGN / TECHNOLOGY'''

Line 61:		Line 63:
	'''PREVIOUS NOTES'''		'''PREVIOUS NOTES'''
	(1) This capability will be provided by the code coming from the CCR-CCD project. The latest project code can be found on http://trac.opensourcevista.net and there are calls almost every Tuesday night at 9 PM Eastern to work on the project. You can sign up to receive notices of the meetings at http://groups.google.com/group/ccd-ccr-project?hl=en . Both a CCR and CCD level 2 are being produced at this time and we are hoping that there will be the capability of transmitting a CCD level 3 in the future as that work is underway. WorldVistA will be submitting a recommendation to the ONCHIT to use both the CCR and CCD as standards for transmission of these health summaries. The production of an XSLT transform to create a CCD level 3 from a CCR, which is the current goal of some work being done by Ken Miller of Solventus as an open source project funded by Oroville Hopital in California, should make this easily possible for healthcare providers.		(1) This capability will be provided by the code coming from the CCR-CCD project. The latest project code can be found on http://trac.opensourcevista.net and there are calls almost every Tuesday night at 9 PM Eastern to work on the project. You can sign up to receive notices of the meetings at http://groups.google.com/group/ccd-ccr-project?hl=en . Both a CCR and CCD level 2 are being produced at this time and we are hoping that there will be the capability of transmitting a CCD level 3 in the future as that work is underway. WorldVistA will be submitting a recommendation to the ONCHIT to use both the CCR and CCD as standards for transmission of these health summaries. The production of an XSLT transform to create a CCD level 3 from a CCR, which is the current goal of some work being done by Ken Miller of Solventus as an open source project funded by Oroville Hopital in California, should make this easily possible for healthcare providers.

	(2)This will also be covered by the CCR-CCD project. Either a CCR or CCD level 2 is something that can be extracted at this time. (see above) This particular standard does not specify how the transmission must be done. It is clear that it must be encrypted but it is not clear how it may be transmitted. Then NHIN is mentioned but there it is not clear that other methods of transport are not allowed such as email with an encrypted attachment. (There is mention that if it is physically transported outside of a healthcare facility, it should be encrypted.)		(2)This will also be covered by the CCR-CCD project. Either a CCR or CCD level 2 is something that can be extracted at this time. (see above) This particular standard does not specify how the transmission must be done. It is clear that it must be encrypted but it is not clear how it may be transmitted. Then NHIN is mentioned but there it is not clear that other methods of transport are not allowed such as email with an encrypted attachment. (There is mention that if it is physically transported outside of a healthcare facility, it should be encrypted.)

			'''DEVELOPMENT STATUS'''

			(Add details here)

	'''ACTION ITEMS / NEXT STEPS'''		'''ACTION ITEMS / NEXT STEPS'''

			(Add details here)

			'''OPEN ISSUES / QUESTIONS'''

	(Add details here)		(Add details here)

Peterbodtke at 20:58, 17 August 2010

2010-08-17T20:58:45Z

← Older revision		Revision as of 20:58, 17 August 2010
Line 1:		Line 1:
	'''SECTION # ''': Section 170.~~302~~(a)~~—Drug-Drug, Drug- Allergy, Drug-Formulary Checks~~		'''SECTION # ''': Section 170.304(i)—Exchange Clinical Information and Patient Summary Record

	'''MU OBJECTIVE''':		'''MU OBJECTIVE''':
	~~Implement drug-drug~~ and ~~drug-allergy interaction checks~~		Capability to exchange key clinical information (for example, discharge summary, procedures, problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically.
			The EP, el

	'''MU STAGE 1 MEASURE'''		'''MU STAGE 1 MEASURE''': Performed at least one test of certified EHR technology's capacity to electronically exchange key clinical information.
	The EP/eligible hospital/CAH ~~has enabled this functionality~~ for ~~the entire EHR reporting period~~		The EP, eligible hospital or CAH who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals.

	'''CERTIFICATION CRITERION'''		'''CERTIFICATION CRITERION'''
			Final Rule Text: §170.304(i)
			(1) Electronically receive and display. Electronically receive and display a patient’s summary record, from other providers and organizations including, at a minimum, diagnostic tests results, problem list, medication list, and medication allergy list in accordance with the standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2).
			Upon receipt of a patient summary record formatted according to the alternative standard, display it in human readable format.

	~~Final Rule Text: §170.302~~(~~a).~~		(2) Electronically transmit. Enable a user to electronically transmit a patient summary record to other providers and organizations including, at a minimum, diagnostic test results, problem list, medication list, and medication allergy list in accordance with:
	(1) ~~Notifications~~. ~~Automatically and~~ electronically ~~generate~~ and ~~indicate in real-time~~, ~~notifications~~ at ~~the point of care for drug- drug and drug-allergy contraindications based on~~ medication list, medication allergy list, and ~~computerized provider order entry~~ (~~CPOE~~).		(i) The standard (and applicable implementation specifications) specified in §170.205(a)(1) or §170.205(a)(2); and
			(ii) For the following data elements the applicable standard must be used:
	(2) ~~Adjustments~~. ~~Provide certain users with~~ the ~~ability to adjust notifications provided for drug-drug~~ and ~~drug-allergy interaction checks~~.		(A) Problems. The standard specified in §170.207(a)(1) or, at a minimum, the version of the standard specified in §170.207(a)(2);
			(B) Laboratory test results. At a minimum, the version of the standard specified in §170.207(c); and
			(C) Medications. The standard specified in §170.207(d).

	'''TEST CRITERIA #'''		'''TEST CRITERIA #'''
	§170.~~302~~ (a)		§170.304(i)
	http://healthcare.nist.gov/docs/170.~~302~~.~~a_DrugDrugDrugAllergy_v1~~.0.pdf		http://healthcare.nist.gov/docs/170.304.i_ExchangeClinicalinforPatientSummaryRecordAmb_v1.0.pdf

	'''STANDARDS'''		'''STANDARDS'''
	~~N/A~~		§170.205(a)(1)
			§170.205(a)(2)
			§170.205(a)(2)
			§170.207(a)(1)
			§170.207(a)(2)
			§170.207(c)
			§170.207(d)
	{\| class="grey" border="1" cellpadding="2"		{\| class="grey" border="1" cellpadding="2"
	! USERS		! USERS
Line 27:		Line 39:
	\|-		\|-
	\| All		\| All
	\| ~~core~~		\| MENU
	\| ~~Oroville~~		\| WorldVistA, et al
	\| ~~In development~~		\| TBD
	\|}		\|}

Line 48:		Line 60:

	'''PREVIOUS NOTES'''		'''PREVIOUS NOTES'''
	~~Note: VistA currently doesn't maintain formularies.~~ This will ~~need to~~ be ~~done with an interface to a 3rd party application, such as~~ the ~~NewCrop ePrescibing service~~. ~~Drug interactions~~ are ~~handled in VistA but because of~~ the ~~additional requirements, the current approach is that ePrescribing is used~~ to ~~check for allergies and interactions as part~~ of ~~that service using~~ the ~~drug database of the ePrescribing service~~. ~~The first service~~ being ~~interfaced with it~~ the ~~NewCrop service which uses~~ the ~~First Databank Database~~ that is the ~~same one the VA was slated~~ to use. The ~~VA was slated~~ to ~~release the source code for that project but the project was stopped as it was running over budget and~~ is ~~under review, so we can't expect any help from~~ the ~~VA code anytime soon. The~~ work being done ~~and~~ funded by Oroville ~~hospital as an extension of~~ the CCR-CCD project ~~to provide ePrescribing~~ is ~~vital to~~ this ~~effort~~. It ~~will~~ be ~~released as open source when~~ it is ~~completed~~.		(1) This capability will be provided by the code coming from the CCR-CCD project. The latest project code can be found on http://trac.opensourcevista.net and there are calls almost every Tuesday night at 9 PM Eastern to work on the project. You can sign up to receive notices of the meetings at http://groups.google.com/group/ccd-ccr-project?hl=en . Both a CCR and CCD level 2 are being produced at this time and we are hoping that there will be the capability of transmitting a CCD level 3 in the future as that work is underway. WorldVistA will be submitting a recommendation to the ONCHIT to use both the CCR and CCD as standards for transmission of these health summaries. The production of an XSLT transform to create a CCD level 3 from a CCR, which is the current goal of some work being done by Ken Miller of Solventus as an open source project funded by Oroville Hopital in California, should make this easily possible for healthcare providers.
			(2)This will also be covered by the CCR-CCD project. Either a CCR or CCD level 2 is something that can be extracted at this time. (see above) This particular standard does not specify how the transmission must be done. It is clear that it must be encrypted but it is not clear how it may be transmitted. Then NHIN is mentioned but there it is not clear that other methods of transport are not allowed such as email with an encrypted attachment. (There is mention that if it is physically transported outside of a healthcare facility, it should be encrypted.)
	~~Eventually the code for ePrescibing can potentially come "in house" so~~ that ~~VistA instances can become their own ePrescribing service~~ with ~~interfaces to the insurance eligibility and formulary databases~~ (~~proprietary), Sure Scripts and the commercial drug databases, but Phase one~~ of ~~this effort is to use the ePrescibing service software provided by the ePrescribing service and to send demographics~~, allergies and medication lists to the service and to return lists augmented by additional information brought back from the service, i.e., additional allergies and medications provided by other providers, etc.
	~~The third item may~~ be ~~difficult to provide in the setting of using the ePrescribing service~~.

	'''ACTION ITEMS / NEXT STEPS'''		'''ACTION ITEMS / NEXT STEPS'''

	(Add details here)		(Add details here)

Peterbodtke at 20:24, 17 August 2010

2010-08-17T20:24:32Z

← Older revision		Revision as of 20:24, 17 August 2010
Line 1:		Line 1:
	==SECTION #==		'''SECTION # ''': Section 170.302(a)—Drug-Drug, Drug- Allergy, Drug-Formulary Checks
	Section 170.302(a)—Drug-Drug, Drug- Allergy, Drug-Formulary Checks
			'''MU OBJECTIVE''':
			Implement drug-drug and drug-allergy interaction checks

			'''MU STAGE 1 MEASURE'''
			The EP/eligible hospital/CAH has enabled this functionality for the entire EHR reporting period

			'''CERTIFICATION CRITERION'''

			Final Rule Text: §170.302(a).
			(1) Notifications. Automatically and electronically generate and indicate in real-time, notifications at the point of care for drug- drug and drug-allergy contraindications based on medication list, medication allergy list, and computerized provider order entry (CPOE).

			(2) Adjustments. Provide certain users with the ability to adjust notifications provided for drug-drug and drug-allergy interaction checks.

			'''TEST CRITERIA #'''
			§170.302 (a)
			http://healthcare.nist.gov/docs/170.302.a_DrugDrugDrugAllergy_v1.0.pdf

			'''STANDARDS'''
			N/A
	{\| class="grey" border="1" cellpadding="2"		{\| class="grey" border="1" cellpadding="2"
	\|-
	~~! STATUS~~
	! USERS		! USERS
	! CORE / MENU		! CORE / MENU
	! DEVELOPMENT OWNER		! DEVELOPMENT OWNER
			! STATUS
	\|-		\|-
	~~\| In development~~
	\| All		\| All
	\| core		\| core
	\| Oroville		\| Oroville
			\| In development
	\|}		\|}
	~~==MU OBJECTIVE==~~
	~~Implement drug-drug and drug-allergy interaction checks~~

	~~==MU STAGE 1 MEASURE==~~		'''SOLUTION DESIGN / TECHNOLOGY'''
	~~The EP~~/~~eligible hospital/CAH has enabled this functionality for the entire EHR reporting period~~

	~~==CERTIFICATION CRITERION==~~		(Add details here)
	~~Final Rule Text: §170.302~~(a).
	(1) Notifications. Automatically and electronically generate and indicate in real-time, notifications at the point of care for drug- drug and drug-allergy contraindications based on medication list, medication allergy list, and computerized provider order entry (CPOE).
	~~(2) Adjustments. Provide certain users with the ability to adjust notifications provided for drug-drug and drug-allergy interaction checks.~~

	~~==TEST CRITERIA #==~~		'''DELIVERABLE'''
	~~§170.302 (a)~~
	~~http://healthcare.nist.gov/docs/170.302.a_DrugDrugDrugAllergy_v1.0.pdf~~

	~~==STANDARDS==~~		(Add details here - Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)
	~~N/A~~

	~~==SOLUTION DESIGN / TECHNOLOGY==~~		'''DEPENDENCIES'''
			(Add details here)

	~~==DELIVERABLE==~~		'''COMMENTS / NOTES'''
	~~(Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)~~
	~~==DEPENDENCIES==~~

	~~==COMMENTS / NOTES==~~		(Add details here)

	==PREVIOUS NOTES ==		'''PREVIOUS NOTES'''
	Note: VistA currently doesn't maintain formularies. This will need to be done with an interface to a 3rd party application, such as the NewCrop ePrescibing service. Drug interactions are handled in VistA but because of the additional requirements, the current approach is that ePrescribing is used to check for allergies and interactions as part of that service using the drug database of the ePrescribing service. The first service being interfaced with it the NewCrop service which uses the First Databank Database that is the same one the VA was slated to use. The VA was slated to release the source code for that project but the project was stopped as it was running over budget and is under review, so we can't expect any help from the VA code anytime soon. The work being done and funded by Oroville hospital as an extension of the CCR-CCD project to provide ePrescribing is vital to this effort. It will be released as open source when it is completed.		Note: VistA currently doesn't maintain formularies. This will need to be done with an interface to a 3rd party application, such as the NewCrop ePrescibing service. Drug interactions are handled in VistA but because of the additional requirements, the current approach is that ePrescribing is used to check for allergies and interactions as part of that service using the drug database of the ePrescribing service. The first service being interfaced with it the NewCrop service which uses the First Databank Database that is the same one the VA was slated to use. The VA was slated to release the source code for that project but the project was stopped as it was running over budget and is under review, so we can't expect any help from the VA code anytime soon. The work being done and funded by Oroville hospital as an extension of the CCR-CCD project to provide ePrescribing is vital to this effort. It will be released as open source when it is completed.

Line 45:		Line 53:
	The third item may be difficult to provide in the setting of using the ePrescribing service.		The third item may be difficult to provide in the setting of using the ePrescribing service.

	==ACTION ITEMS / NEXT STEPS==		'''ACTION ITEMS / NEXT STEPS'''

			(Add details here)

Peterbodtke at 18:19, 17 August 2010

2010-08-17T18:19:02Z

← Older revision		Revision as of 18:19, 17 August 2010
Line 2:		Line 2:
	Section 170.302(a)—Drug-Drug, Drug- Allergy, Drug-Formulary Checks		Section 170.302(a)—Drug-Drug, Drug- Allergy, Drug-Formulary Checks
	{\| class="grey" border="1" cellpadding="2"		{\| class="grey" border="1" cellpadding="2"
	~~\|+ Caption Here~~
	\|-		\|-
	! STATUS		! STATUS

Peterbodtke at 18:14, 17 August 2010

2010-08-17T18:14:32Z

New page

==SECTION #==
Section 170.302(a)—Drug-Drug, Drug- Allergy, Drug-Formulary Checks
{| class="grey" border="1" cellpadding="2"
|+ Caption Here
|-
! STATUS
! USERS
! CORE / MENU
! DEVELOPMENT OWNER
|-
| In development
| All
| core
| Oroville
|}
==MU OBJECTIVE==
Implement drug-drug and drug-allergy interaction checks

==MU STAGE 1 MEASURE==
The EP/eligible hospital/CAH has enabled this functionality for the entire EHR reporting period

==CERTIFICATION CRITERION==
Final Rule Text: §170.302(a).
(1) Notifications. Automatically and electronically generate and indicate in real-time, notifications at the point of care for drug- drug and drug-allergy contraindications based on medication list, medication allergy list, and computerized provider order entry (CPOE).
(2) Adjustments. Provide certain users with the ability to adjust notifications provided for drug-drug and drug-allergy interaction checks.

==TEST CRITERIA #==
§170.302 (a)
http://healthcare.nist.gov/docs/170.302.a_DrugDrugDrugAllergy_v1.0.pdf

==STANDARDS==
N/A

==SOLUTION DESIGN / TECHNOLOGY==

==DELIVERABLE==
(Ex. KIDS patch, Delphi code, User guide, Web resources, Manual test script, etc)
==DEPENDENCIES==

==COMMENTS / NOTES==

==PREVIOUS NOTES ==
Note: VistA currently doesn't maintain formularies. This will need to be done with an interface to a 3rd party application, such as the NewCrop ePrescibing service. Drug interactions are handled in VistA but because of the additional requirements, the current approach is that ePrescribing is used to check for allergies and interactions as part of that service using the drug database of the ePrescribing service. The first service being interfaced with it the NewCrop service which uses the First Databank Database that is the same one the VA was slated to use. The VA was slated to release the source code for that project but the project was stopped as it was running over budget and is under review, so we can't expect any help from the VA code anytime soon. The work being done and funded by Oroville hospital as an extension of the CCR-CCD project to provide ePrescribing is vital to this effort. It will be released as open source when it is completed.

Eventually the code for ePrescibing can potentially come "in house" so that VistA instances can become their own ePrescribing service with interfaces to the insurance eligibility and formulary databases (proprietary), Sure Scripts and the commercial drug databases, but Phase one of this effort is to use the ePrescibing service software provided by the ePrescribing service and to send demographics, allergies and medication lists to the service and to return lists augmented by additional information brought back from the service, i.e., additional allergies and medications provided by other providers, etc.
The third item may be difficult to provide in the setting of using the ePrescribing service.

==ACTION ITEMS / NEXT STEPS==